Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
about
β(2) -adrenoceptor agonists: current and future directionDifferential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolPharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.Regiospecific synthesis of neuroprotective 1,4-benzoxazine derivatives through a tandem oxidation-Diels-Alder reaction.The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation.Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease.Olodaterol for the treatment of asthma.Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD.Next generation beta adrenoreceptor agonists for the treatment of asthma.Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.Olodaterol and vilanterol detection in sport drug testing.G-protein coupled receptor and kinase targets: advances in drug discovery from molecular to clinical.
P2860
Q24604047-7D841250-827F-4CA4-865C-0C5EF1A77769Q26775244-2029B77A-853D-404A-957F-78A34ACA3849Q26777927-E25A3F6A-8A19-45A6-8291-EE3A191673ACQ30397854-3294A876-BB95-4876-8853-C1304DC4817AQ33783760-712E3106-0E1A-4745-9C6E-671B33A20DFFQ34123296-97F3FC79-7F82-4773-87F0-49B9A7FB2697Q35562211-51349A18-9C49-49F0-81C2-1D07140C4B61Q35865433-0F909D69-AF04-4501-B5E5-892F31684592Q35994264-AA2072E3-3D8C-4E7B-A9CD-DA52AE082DFAQ37804908-9600B81A-00C0-4397-BE54-63393EB85ABBQ37937549-A7FFC927-1A36-4195-AD96-634978C5EE3BQ37937552-FCADE14B-D714-45B9-A364-F356E8BB2A46Q38241442-8DE99EA0-5FA2-480C-84B9-95B4FD0A044FQ38832470-12E89E24-27F3-4432-A3C6-4C34F636D6CFQ39782286-D4309B28-7DD2-401E-B9AE-324E1F6FFEA6Q47664891-D3E67862-EA4D-4BCD-914A-F3A458B791D2Q47777308-00108AF4-BA56-4BFE-B807-C4CC3D18CE36Q47801444-6DF24A27-6A8A-419C-820A-82581D3C2565Q48100516-E234F155-E787-461C-A57F-8F392F90527FQ51690191-1900AB83-9569-4101-A836-0A1BAC2CC0C9
P2860
Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@ast
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@en
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@nl
type
label
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@ast
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@en
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@nl
prefLabel
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@ast
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@en
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@nl
P2093
P1476
Discovery of olodaterol, a nov ...... 24 h bronchodilatory efficacy.
@en
P2093
Andreas Schnapp
Christoph Hoenke
Claudia Heine
Frank H Büttner
Ingo Konetzki
Klaus Rudolf
Peter Sieger
Philipp Lustenberger
Sabine Pestel
P304
P356
10.1016/J.BMCL.2009.12.087
P407
P577
2010-01-04T00:00:00Z